Doximity’s fourth annual Physician Compensation Report shows a widening of the gender pay gap. From biologics and investigational molecules for psoriasis to socks to prevent foot odors, the European Academy of Dermatology and Venereology annual meeting highlights emerging therapies for dermatology patients. Chef Aarón Sánchez uses his personal experience with psoriasis to raise awareness of the condition and encourage open dialogue among those affected by it.
The FDA has approved Winlevi (Clascoterone cream 1%) from Cassiopea for the treatment of acne in patients 12 years and older.New Guidelines of care for the Management of Psoriasis with Systemic Nonbiologic Therapies, jointly issued by the American Academy of Dermatology and the National Psoriasis Foundation, cover a total of 12 non-biologic systemic treatments used—many off-label—for the treatment of psoriasis. Singer, songwriter, actress, and activist Cyndi Lauperhosts “PsO in the Know,” a new podcast series highlighting the impact of psoriasis. Sarah Michelle Gellar is the international ambassador for CoolSculpting in partnership withAllergan Aesthetics, an AbbVie company.
The vast majority of dermatologists around the world—95.6 percent—believe climate change is occurring, and 88 percent think it will impact the incidence of skin diseases, according to the first international survey of dermatologists on the topic, conducted online by the International Society of Dermatology's Climate Change Committee. FDA has approved MC2 Therapeutics Wynzora Cream for once-daily topical treatment of plaque psoriasis in adults. Tremfya is the first IL-23 inhibitor FDA-approved for active psoriatic arthritis. AbbVie's upadacitinib met both primary and all secondary endpoints in Measure Up 2, the second Phase 3 study in individuals with moderate to severe atopic dermatitis.
SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients ages 6 to under 18. LEO Pharma’s Finacea Foam (azelaic acid 15%) is back in pharmacies—just in time for Rosacea Awareness Month.
Explore efficacy and safety data for ILUMYA™ from the reSURFACE 1 and reSURFACE 2 Phase 3 trials and extension studies.
Learn about the immunopathogenesis of plaque psoriasis, and how the IL-23 inhibitor ILUMYA™ controls the release of key cytokines to...
Bristol Myers Squibb's Deucravacitinib Performs Well in Phase 2 Study in Patients with Psoriatic Arthritis
DermWireTV: Doximity Physician Compensation Report, EADV Updates, PsO in the Know
Ilumya Shows 5-Year Sustained Efficacy and Safety in Moderate-to-Severe Plaque Psoriasis
EADV Congress Update: Insights on Psoriasis, AD, UV Protection, COVID-19, and More
Coping with COVID: Most Psoriasis Patients Taking Immunosuppressants Survive COVID-19